BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15585451)

  • 1. Treating serious infections: focus on cefepime.
    Wong-Beringer A
    Pharmacotherapy; 2004 Dec; 24(12 Pt 2):216S-23S. PubMed ID: 15585451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefepime versus ceftazidime: considerations for empirical use in critically ill patients.
    Roberts JA; Webb SA; Lipman J
    Int J Antimicrob Agents; 2007 Feb; 29(2):117-28. PubMed ID: 17158033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of gram-negative bacteria in healthcare-associated pneumonia.
    Restrepo MI; Anzueto A
    Semin Respir Crit Care Med; 2009 Feb; 30(1):61-6. PubMed ID: 19199188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Practical use of cefepime in an University hospital. Retrospective study of 35 cases].
    GĂ©rard A; Le Meins V; Maurer P; Witz B; Dopff C
    Pathol Biol (Paris); 1996 Feb; 44(2):138-40. PubMed ID: 8761599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of carbapenems in the treatment of severe nosocomial respiratory tract infections.
    Joseph J; Rodvold KA
    Expert Opin Pharmacother; 2008 Mar; 9(4):561-75. PubMed ID: 18312158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotics in childhood pneumonia.
    Hale KA; Isaacs D
    Paediatr Respir Rev; 2006 Jun; 7(2):145-51. PubMed ID: 16765302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Once-daily cefepime versus ceftriaxone for nursing home-acquired pneumonia.
    Paladino JA; Eubanks DA; Adelman MH; Schentag JJ
    J Am Geriatr Soc; 2007 May; 55(5):651-7. PubMed ID: 17493183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis and treatment strategies in respiratory infections for respiratory surgeons].
    Fujita J
    Kyobu Geka; 2007 Jul; 60(7):565-74. PubMed ID: 17642219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Panipenem versus cefepime as empirical monotherapy in adult cancer patients with febrile neutropenia: a prospective randomized trial.
    Kwon KT; Cheong HS; Rhee JY; Wi YM; Ryu SY; Heo ST; Moon CS; Ki HK; Kim KH; Jung CW; Peck KR; Song JH
    Jpn J Clin Oncol; 2008 Jan; 38(1):49-55. PubMed ID: 18203711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefepime monotherapy for treatment of febrile neutropenia in children.
    Ariffin H; Ai CL; Lee CL; Abdullah WA
    J Paediatr Child Health; 2006 Dec; 42(12):781-4. PubMed ID: 17096713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of cefepime in the treatment of hospital-acquired pneumonia].
    Iakovlev SV; Romashov OM
    Antibiot Khimioter; 2005; 50(4):27-32. PubMed ID: 16392337
    [No Abstract]   [Full Text] [Related]  

  • 12. Extended-spectrum beta-lactamases and clinical outcomes: current data.
    Ramphal R; Ambrose PG
    Clin Infect Dis; 2006 Apr; 42 Suppl 4():S164-72. PubMed ID: 16544267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-risk febrile neutropenia in Auckland 2003-2004: the influence of the microbiology laboratory on patient treatment and the use of pathogen-specific therapy.
    Ritchie S; Palmer S; Ellis-Pegler R
    Intern Med J; 2007 Jan; 37(1):26-31. PubMed ID: 17199841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial resistance in nosocomial bloodstream infection associated with pneumonia and the value of systematic surveillance cultures in an adult intensive care unit.
    Depuydt PO; Blot SI; Benoit DD; Claeys GW; Verschraegen GL; Vandewoude KH; Vogelaers DP; Decruyenaere JM; Colardyn FA
    Crit Care Med; 2006 Mar; 34(3):653-9. PubMed ID: 16505649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of broad-spectrum antimicrobials for the treatment of pneumonia in seriously ill patients: maximizing clinical outcomes and minimizing selection of resistant organisms.
    Niederman MS
    Clin Infect Dis; 2006 Jan; 42 Suppl 2():S72-81. PubMed ID: 16355320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antibiotic strategies in the treatment of infection in critically ill patients].
    Schierbeck J; Kolmos HJ
    Ugeskr Laeger; 2007 Feb; 169(8):699-702. PubMed ID: 17313920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of quantitative cultures and reduced duration of antibiotic regimens for patients with ventilator-associated pneumonia to decrease resistance in the intensive care unit.
    Chastre J; Luyt CE; Combes A; Trouillet JL
    Clin Infect Dis; 2006 Sep; 43 Suppl 2():S75-81. PubMed ID: 16894519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of nursing home-acquired pneumonia.
    Mills K; Graham AC; Winslow BT; Springer KL
    Am Fam Physician; 2009 Jun; 79(11):976-82. PubMed ID: 19514695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial treatment of hospital-acquired pneumonia.
    Fagon JY; Chastre J
    Clin Chest Med; 2005 Mar; 26(1):97-104. PubMed ID: 15802171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is ventilator-associated pneumonia and why is it important?
    Kollef MH
    Respir Care; 2005 Jun; 50(6):714-21; discussion 721-4. PubMed ID: 15913464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.